• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Gentherm Announces Dr. Ken Washington as New Independent Director

    10/2/23 8:00:00 AM ET
    $AMZN
    $F
    $MCK
    $MDT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Consumer Discretionary
    Get the next $AMZN alert in real time by email

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023.

    Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic's portfolio. Prior to joining Medtronic, Dr. Washington served as the Vice President of Software Engineering, Consumer Robotics for Amazon Lab126, a premier innovation hub and subsidiary of Amazon.com, Inc. (NASDAQ:AMZN). At Amazon Lab 126, Dr. Washington was responsible for all aspects of the profitability of Amazon's consumer robotics business unit. Before Amazon Lab 126, he held varying positions at Ford Motor Company (NYSE:F), including serving as Chief Technology Officer. At Ford, he led the worldwide research organization, oversaw the development and implementation of Ford's technology strategy and plans, oversaw the autonomous vehicle program, and played a key role in Ford's expansion into emerging mobility opportunities. Dr. Washington worked at Lockheed Martin Corporation as Vice President of the Advanced Technology Center and its first Chief Privacy Officer. Dr. Washington also served for approximately 21 years in various roles at Sandia National Laboratories, including as Chief Information Officer.

    Dr. Washington previously served as a member of the Board of Directors of McKesson Corporation (NYSE:MCK) from July 2019 to October 2021, including as a member of the Compliance and Finance Committees, as well as numerous private company boards and advisory boards of academic institutions.

    "We are pleased to welcome Ken to Gentherm's Board of Directors," said Ronald Hundzinski, Chair of the Board of Gentherm. "Ken brings years of experience in technology, research, and strategy across global automotive and medical organizations that will be a valuable asset to Gentherm's Board."

    "Ken's strong track record of leading technology development and execution makes him an ideal Board member to help drive innovation and strategy to strengthen shareholder value," said Phil Eyler, President and CEO of Gentherm. "I look forward to his insight and counsel and am excited for him to join as a new member of our Board of Directors."

    Dr. Washington earned his bachelor's, master's, and doctorate degrees in nuclear engineering from Texas A&M University.

    Investor Contact

    Yijing Brentano

    [email protected]

    248.308.1702

    Media Contact

    Melissa Fischer

    [email protected]

    248.289.9702

    About Gentherm

    Gentherm (NASDAQ:THRM) is the global market leader in innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests, and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.



    Primary Logo

    Get the next $AMZN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AMZN
    $F
    $MCK
    $MDT

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    7/11/2025$240.00 → $255.00Overweight
    Analyst
    Amazon.com Inc.
    $AMZN
    7/10/2025Mkt Outperform
    Citizens JMP
    Amazon.com Inc.
    $AMZN
    7/8/2025$201.00 → $238.00Equal Weight
    Wells Fargo
    Amazon.com Inc.
    $AMZN
    7/2/2025$226.00 → $250.00Buy
    Truist
    Medtronic plc.
    $MDT
    6/30/2025Underperform → Peer Perform
    Wolfe Research
    Amazon.com Inc.
    $AMZN
    6/27/2025$254.00Neutral → Outperform
    BNP Paribas Exane
    Amazon.com Inc.
    $AMZN
    6/24/2025$250.00 → $253.00Buy
    MoffettNathanson
    Medtronic plc.
    $MDT
    6/16/2025$110.00Outperform
    Leerink Partners
    More analyst ratings

    $AMZN
    $F
    $MCK
    $MDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Chair Bezos Jeffrey P sold $108,682,627 worth of shares (485,205 units at $223.99), decreasing direct ownership by 0.05% to 901,995,325 units (SEC Form 4)

      4 - AMAZON COM INC (0001018724) (Issuer)

      7/10/25 4:12:08 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Executive Chair Bezos Jeffrey P sold $665,864,143 worth of shares (2,974,445 units at $223.86), decreasing direct ownership by 0.33% to 902,480,530 units (SEC Form 4)

      4 - AMAZON COM INC (0001018724) (Issuer)

      7/8/25 4:13:43 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • CEO Worldwide Amazon Stores Herrington Douglas J sold $550,144 worth of shares (2,500 units at $220.06), decreasing direct ownership by 0.48% to 514,550 units (SEC Form 4)

      4 - AMAZON COM INC (0001018724) (Issuer)

      7/3/25 5:39:47 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • March 11, 2025 - FDA Roundup: March 11, 2025

      For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

      3/13/25 3:14:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • November 14, 2023 - FDA Roundup: November 14, 2023

      For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

      11/14/23 3:26:18 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Gentherm Announces Date for 2025 Second Quarter News Release and Conference Call

      NOVI, Mich., July 09, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the second quarter 2025 on Thursday, July 24, 2025, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13754880 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximately

      7/9/25 4:30:00 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • Buy with Prime Expands with New Brand Dr. Berg Nutritionals

      Dr. Berg customers now enjoy the power of Amazon's fulfillment network and the trust and recognition of the Prime brand Through fast, free delivery, easy returns, and 24/7 shopper support, Buy with Prime enhances the Dr. Berg shopping experience Prime members get the familiar shopping benefits they know and love while using Buy with Prime on Dr. Berg's website Amazon (NASDAQ:AMZN) today announced that Buy with Prime, a direct-to-customer (DTC) offering, is now available on Dr. Berg Nutritionals, a health supplements provider. For millions of U.S.-based Prime members, Buy with Prime is a benefit that unlocks even more selection of popular brands beyond the Amazon store in addition to t

      7/9/25 9:55:00 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • James Gunn Receives the First-Ever IMDb "Fan Favorite Filmmaker" Award

      IMDbPro MOVIEmeter data shows Superman, written, directed and produced by Gunn and slated for release on July 11, is the most anticipated movie of 2025 IMDb (www.imdb.com), the world's most popular and authoritative source for information on movies, TV shows, and celebrities, today presented its first-ever "Fan Favorite Filmmaker" Award to James Gunn. This new category reflects the growing interest of global audiences in the visionaries behind the camera, expanding the prestigious IMDb STARmeter Award program to celebrate the creators who shape entertainment. The award is determined by IMDbPro MOVIEmeter rankings, which track page views from the global audience of hundreds of millions on

      7/8/25 12:00:00 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Washington Kenneth E bought $47,702 worth of shares (1,700 units at $28.06), increasing direct ownership by 18% to 10,965 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      5/13/25 4:10:38 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • Director Hundzinski Ronald T bought $133,350 worth of shares (5,000 units at $26.67), increasing direct ownership by 38% to 18,006 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      5/12/25 4:06:43 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • SVP, General Manager, Europe Stocker Thomas bought $8,011 worth of shares (321 units at $24.96), increasing direct ownership by 2% to 20,638 units (SEC Form 4)

      4 - Gentherm Inc (0000903129) (Issuer)

      4/29/25 8:46:29 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    SEC Filings

    See more
    • SEC Form 144 filed by McKesson Corporation

      144 - MCKESSON CORP (0000927653) (Subject)

      7/11/25 10:43:52 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form DEFA14A filed by McKesson Corporation

      DEFA14A - MCKESSON CORP (0000927653) (Filer)

      7/2/25 4:18:08 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 25-NSE filed by Medtronic plc.

      25-NSE - Medtronic plc (0001613103) (Subject)

      7/2/25 1:17:58 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Analyst reiterated coverage on Amazon with a new price target

      Analyst reiterated coverage of Amazon with a rating of Overweight and set a new price target of $255.00 from $240.00 previously

      7/11/25 8:35:50 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Citizens JMP resumed coverage on Amazon

      Citizens JMP resumed coverage of Amazon with a rating of Mkt Outperform

      7/10/25 11:09:42 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Wells Fargo reiterated coverage on Amazon with a new price target

      Wells Fargo reiterated coverage of Amazon with a rating of Equal Weight and set a new price target of $238.00 from $201.00 previously

      7/8/25 9:08:18 AM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Leadership Updates

    Live Leadership Updates

    See more
    • Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

      GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

      7/8/25 8:45:00 AM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Medtronic Board appoints Dr. Joon Lee as a new director

      GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

      6/23/25 4:15:00 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Ford Names Kyle Crockett as Chief Accounting Officer

      Ford Motor Company today announced the appointment of Kyle Crockett to the role of Chief Accounting Officer (CAO). In that role, he will have responsibility for all aspects of Ford's accounting function and internal control over financial reporting. Crockett's appointment will be effective the first business day after the company files its second quarter Form 10-Q. In the interim, he will serve as Vice President, Accounting, reporting to Chief Financial Officer Sherry House. Crockett brings a wealth of experience in accounting, SEC and financial reporting, internal controls, process and system transformation, and tax to his new position. Most recently, he served as Vice President, Controll

      5/13/25 8:00:00 AM ET
      $F
      Auto Manufacturing
      Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

      SC 13G/A - AMAZON COM INC (0001018724) (Subject)

      11/8/24 4:33:15 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

      SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

      11/7/24 5:23:12 PM ET
      $AMZN
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

      SC 13G/A - Medtronic plc (0001613103) (Subject)

      2/13/24 5:09:43 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Financials

    Live finance-specific insights

    See more
    • Gentherm Announces Date for 2025 Second Quarter News Release and Conference Call

      NOVI, Mich., July 09, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the second quarter 2025 on Thursday, July 24, 2025, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13754880 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximately

      7/9/25 4:30:00 PM ET
      $THRM
      Auto Parts:O.E.M.
      Consumer Discretionary
    • McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

      McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

      6/26/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation Completes Acquisition of Core Ventures

      Strengthens Community-Based Oncology Care with Florida Cancer Specialists & Research Institute Core Ventures McKesson Corporation (NYSE:MCK) announced today that it has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC (FCS). The acquisition advances community-based oncology care and enables McKesson to continue to accelerate clinical development, improve patient outcomes, and expand access to quality cancer care in local communities. McKesson acquired an approximate 70% controlling intere

      6/3/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care